key: cord-0826703-6lu14y0l
authors: Chan, Kok Hoe; Lim, Su Lin; Damati, Ahmad; Maruboyina, Siva Prasad; Bondili, Leena; Hanoud, Amany Abu; Slim, Jihad
title: Coronavirus disease 2019 (COVID-19) and ischemic colitis: An under-recognized complication
date: 2020-05-27
journal: Am J Emerg Med
DOI: 10.1016/j.ajem.2020.05.072
sha: 338205253d054cef55bc0d56c1c1f3088bb5e670
doc_id: 826703
cord_uid: 6lu14y0l

COVID-19 has spread worldwide, with more than 2.5 million cases and over 80,000 deaths reported by the end of April 2020. In addition to pulmonary symptoms, gastrointestinal symptoms have been increasingly recognized as part of the disease spectrum. COVID-19-associated coagulopathy has recently emerged as a major component of the disease, leading to high morbidity and mortality. Ischemic colitis has been reported to be associated with a hypercoagulable state. To our knowledge, there have not been any case reports of COVID-19 associated with ischemic colitis. Herein, we present the first case of a probable association of COVID-19 with ischemic colitis in a patient with a hypercoagulable state.

J o u r n a l P r e -p r o o f Introduction:

The first case of COVID-19 was caused by severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2), which was reported in Wuhan, China, in December 2019 [1] . Since then, COVID-19 has spread across the globe, with more than 2.5 million individuals affected by the end of April 2020 [2] . SARS-Cov-2 has been identified as a novel enveloped RNA betacoronavirus that belongs to the same family as SARS-CoV. Similar to those with SARS-CoV, patients with SARS-CoV-2 infection tend to present with upper and lower respiratory tract symptoms [3] , as well as gastrointestinal symptoms, which can be present in up to 50% as reported by some studies [4] . Coagulopathy with elevated levels of D-dimer and fibrinogen has also been well described in COVID-19 patients and has been associated with increased morbidity and mortality [5] . Ischemic colitis, a condition that results from a lack of arterial blood supply to the colon, has been linked to hypercoagulable states [6] . To the best of our knowledge, there has been no case report of ischemic colitis described in patients with COVID-19. We are the first to report this important finding.

J o u r n a l P r e -p r o o f Case report:

A 73-year-old gentleman with a past medical history of hypertension and end-stage renal disease on hemodialysis presented to the Emergency Department with a syncopal episode. He also complained of fever, nonproductive cough, shortness of breath on exertion and 5 to 6 episodes of bloody diarrhea for the past three days. He denied any recent use of nonsteroidal anti-inflammatory drugs (NSAIDs), antiplatelets or anticoagulants. At initial presentation, he was afebrile and hemodynamically stable, and his oxygen saturation was 97% at rest in room air, while on exertion, the oxygen saturation dropped to 88%. Physical examination was only remarkable for tenderness over the left lower quadrant region, but otherwise, there was a nondistended abdomen, no guarding and no rebound tenderness. Digital rectal examination showed internal hemorrhoids and yellow tinged stool. Twelve hours postadmission, he complained of sudden, severe left lower quadrant cramping pain with bright red blood from the rectum. Vital signs were stable throughout admission with no episodes of hypotension.

His hemoglobin was low, at a level of 5.6 g/dL (13.5-17.5 g/dL), and the mean corpuscular volume (MCV) was 86.1 fL (81.2-95.1 fL), iron was 18 ug/dL (50-150 ug/dL), TIBC was 98 ug/dL (250-400 ug/dL), and iron saturation was 18.4% (20-55%). White cell counts showed leucopenia 3.8 (4.4-11 X10 3 /µL), lymphopenia with an absolute lymphocyte count of 600 (900-2900/µL), and the lactic acid level was 2 (0-2 mmol/L). Chest X-ray showed diffuse bilateral reticular infiltration with ill-defined areas of opacity ( Figure 1 ). Computed tomography (CT) of the abdomen and pelvis showed mucosal hyperenhancement with masslike thickening of the distal sigmoid colon, and regional air within the mesenteric vessels as a concern for ischemic colitis was also noted ( ng/ml (0-500 ng/ml), ferritin was 783 ng/ml (24-336 ng/mL), C-reactive protein (CRP) was 7.7 mg/dL (0-0.8 mg/dL), and procalcitonin was 1.65 ng/ml (0-0.5 ng/mL). A nasopharyngeal swab for SARS-CoV-2 RT-PCR was positive. The prothrombin time was 13.5 seconds (9.9-13 seconds), and the INR was 1.18 (0.9-1.1). Sigmoidoscopy or colonoscopy was not performed, as the patient presented with typical symptoms of ischemic colitis with sudden left lower quadrant cramping pain with bloody diarrhea, and CT findings demonstrated mucosal hyperenhancement with mass-like thickening of the distal sigmoid colon and regional air within the mesenteric vessels. The patient was initially managed conservatively with bowel rest and intravenous fluids, and the antibiotics ciprofloxacin and metronidazole were started. Surgery was considered, and the surgical team did not feel that a surgical intervention would be of benefit. Anticoagulation was also started in light of the hypercoagulable state but was put on hold after a significant drop in hemoglobin was COVID-19 is a public health emergency. The World Health Organization (WHO) designated the disease as coronavirus disease 2019 in February 2020 and subsequently declared it as a pandemic in March 2020 after worldwide spread [7] . COVID-19 has multifaceted presentations, with symptoms ranging from asymptomatic to rapid multiple organ dysfunction syndrome, and has high mortality. A critical disease presentation with shock, acute respiratory failure and multiorgan dysfunction has only been reported in approximately 5% of cases, with an overall case fatality rate of 2.3% [8].

In addition to pulmonary symptoms that are typically described in patients with COVID-19, gastrointestinal symptoms such as abdominal pain, nausea, vomiting, non-bloody diarrhea and transaminitis have been identified as part of the disease spectrum [9] [10] [11] . Some case series have noted that 3% to 10% of COVID-19 patients initially present with isolated gastrointestinal symptoms [11] . It has been well recognized that the target viral receptor for this novel beta-coronavirus is the angiotensin-converting enzyme 2 (ACE-2) receptor [12] [13] [14] . ACE-2 is not only expressed in alveolar cells but also highly expressed in the esophagus, gastric epithelial cells and small intestinal as well as colonic cells [13] [14] [15] [16] . Moreover, SARS-CoV-2 RNA has been found in fecal samples from patients with COVID-19 [12] , indicating the potential for this virus to invade the gastrointestinal tract.

Ischemic colitis is a condition resulting from a decreased blood supply to the colon leading to mucosal injury, cellular ischemia and necrosis [17] . Multiple etiologies of ischemic colitis have been described, and they are divided into occlusive (acute embolic and thrombotic occlusion, mesenteric vein thrombosis and venous thrombosis) and nonocclusive (hypoperfusion secondary to hemodialysis, shock, pancreatitis and cardiac failure) [18] . The J o u r n a l P r e -p r o o f clinical presentation of ischemic colitis can be divided into three stages. Patients will initially present with severe abdominal pain with bloody diarrhea and hyperactive bowel sounds, followed by the paralytic phase with diffuse abdominal pain and the absence of bowel sounds; the last phase is known as the shock phase, which is characterized by metabolic acidosis [19, 20] . The "watershed" areas of the colon (rectosigmoid junction and splenic flexure) are particularly prone to ischemia with limited collateral blood circulation [21] .

Thrombosis forming around this area will lead to colonic ischemia or ischemic colitis.

Hypercoagulable states have been recognized as one of the risk factors for ischemic colitis, although the extent of how the coagulable state leads to ischemic colitis is not well understood. COVID-19-associated coagulopathy is a well-defined phenomenon and has been associated with poor prognosis [22] . COVID-19 patients have been reported to have marked increases in D-dimer and fibrinogen levels, which predispose them to a high risk of microand macro-circulatory thrombosis [22] . It was suggested that the hypercoagulability observed in COVID-19 was related to the high inflammatory state associated with a -cytokine storm‖ rather than a progression of disseminated intravascular coagulation (DIC) [23] . To the best of our knowledge, SARS-CoV-2-induced ischemic colitis has never been reported in the literature.

Our patient had underlying risk factors for ischemic colitisatherosclerotic heart disease and end-stage renal disease on hemodialysis. The observed ischemic colitis in the setting of Figure 1 : Chest X-ray showed diffuse bilateral reticular infiltrates with ill-defined areas of opacity that were more predominant on the right 

Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding

Clinical Characteristics of COVID-19 Patients with Digestive Symptoms in Hubei, China: A Descriptive, Cross-Sectional, Multicenter Study

COVID-19-Related Severe Hypercoagulability in Patients Admitted to Intensive Care Unit for Acute Respiratory Failure

The role of hypercoagulability in ischemic colitis

Director-General's remarks at the media briefing on 2019-nCoV on 11

Clinical Characteristics of 138 Hospitalized Patients with 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China

Clinical characteristics of COVID-19 patients with digestive symptoms in Hubei, China: a descriptive, cross-sectional, multicenter study

Evidence for gastrointestinal infection of SARS-Cov-2

Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus

Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis

Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection

Single-cell RNA expression profiling of ACE2, the putative receptor of Wuhan 2019-nCov. Preprint pending peer review

American College of Gastroenterology. ACG clinical guideline: epidemiology, risk factors, patterns of presentation, diagnosis, and management of colon ischemia (CI)

Management of ischemic colitis

Mesenteric ischemia

Colon ischemia: recent insights and advances

Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia

Ischemic colitis